MSLN-targeted CAR-T Cells in Solid Tumors.
Clinical trial NCT05783089 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05783089
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2025-04-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.